These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6531385)

  • 21. Substituted piperazines as central serotonin agonists: comparative specificity of the postsynaptic actions of quipazine and m-trifluoromethylphenylpiperazine.
    Fuller RW; Snoddy HD; Mason NR; Hemrick-Luecke SK; Clemens JA
    J Pharmacol Exp Ther; 1981 Sep; 218(3):636-41. PubMed ID: 6167711
    [No Abstract]   [Full Text] [Related]  

  • 22. Head twitches induced by LSD and quipazine: similarities and differences.
    Vetulani J; Bednarczyk B; Reichenberg K; Rokosz A
    Neuropharmacology; 1980 Feb; 19(2):155-8. PubMed ID: 6244515
    [No Abstract]   [Full Text] [Related]  

  • 23. Blockade of 5-hydroxytryptamine (5-HT) receptors by quipazine [proceedings].
    Lansdown MR; Nash HL; Preston PR; Wallis DI
    Br J Pharmacol; 1979 May; 66(1):80P-81P. PubMed ID: 454965
    [No Abstract]   [Full Text] [Related]  

  • 24. Different behavioral mechanisms underlie tolerance to the anorectic effects of fenfluramine and quipazine.
    Rowland N; Carlton J
    Psychopharmacology (Berl); 1983; 81(2):155-7. PubMed ID: 6415747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A possible interaction of quipazine with central dopamine structures.
    Grabowska M; Antkiewicz L; Michaluk J
    J Pharm Pharmacol; 1974 Jan; 26(1):74-6. PubMed ID: 4150944
    [No Abstract]   [Full Text] [Related]  

  • 26. Evidence for the role of noradrenaline in some effects of quipazine.
    Francès H; Lecrubier Y; Puech AJ; Simon P
    Psychopharmacology (Berl); 1980; 67(3):307-10. PubMed ID: 6770410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Neurochemical analysis of the mechanism of action of serotoninergic substances on avoidance behavior in situations of acute stress].
    Shelekhov SL; Val'dman AV
    Biull Eksp Biol Med; 1984 Apr; 97(4):423-6. PubMed ID: 6232963
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of quipazine and of tryptamine on self-stimulation of median raphé nucleus and of lateral hypothalamus in rats.
    Broadbent J; Greenshaw AJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):943-7. PubMed ID: 4080780
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of the retinohypothalamic tract in the photic-like effects of the serotonin agonist quipazine in the rat.
    Graff C; Kohler M; Pévet P; Wollnik F
    Neuroscience; 2005; 135(1):273-83. PubMed ID: 16084651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of TR2515, a serotonin antagonist, on the electrical and behavioral effects induced by stimulation of the olivo-cerebellar system.
    Barragan LA; Galindo-Morales JA; Hong E
    Proc West Pharmacol Soc; 1984; 27():329-32. PubMed ID: 6494172
    [No Abstract]   [Full Text] [Related]  

  • 31. The comparative roles of dopaminergic and serotonergic mechanisms in mediating quipazine induced locomotor activity.
    Feigenbaum JJ; Yanai J; Klawans HL
    J Neural Transm; 1982; 54(3-4):145-51. PubMed ID: 7130970
    [No Abstract]   [Full Text] [Related]  

  • 32. Aggressive behavior inhibition by serotonin and quipazine injected into the amygdala in the rat.
    Puciłowski O; Płaźnik A; Kostowski W
    Behav Neural Biol; 1985 Jan; 43(1):58-68. PubMed ID: 4039562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The central antiserotonergic action of mianserin.
    Maj J; Sowińska H; Baran L; Gancarczyk L; Rawłów A
    Psychopharmacology (Berl); 1978 Sep; 59(1):79-84. PubMed ID: 100819
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of intracerebroventricularly administered octopamine, phenylethylamine and epinephrine on the central serotonergic system of the rat.
    Jagiełło-Wójtowicz E
    Pol J Pharmacol Pharm; 1982; 34(4):193-200. PubMed ID: 6820690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of quipazine and methysergide on play in juvenile rats.
    Normansell L; Panksepp J
    Pharmacol Biochem Behav; 1985 May; 22(5):885-7. PubMed ID: 2989950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of the locus coeruleus in the potentiation of the quipazine-induced head-twitch response by diazepam and beta-adrenoceptor agonists.
    Handley SL; Singh L
    Neuropharmacology; 1986 Dec; 25(12):1315-21. PubMed ID: 2882436
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quipazine and induction of adrenal enzymes.
    Ekker M; Missala K; Sourkes TL
    Biochem Pharmacol; 1984 May; 33(10):1687-9. PubMed ID: 6145420
    [No Abstract]   [Full Text] [Related]  

  • 38. Some behavioral effects induced by quipazine administration in the cat.
    Guzmán-Flores C; Pacheco P; Hong E; Pardo EG
    Bol Estud Med Biol; 1970 Apr; 26(6):225-32. PubMed ID: 5514964
    [No Abstract]   [Full Text] [Related]  

  • 39. Quipazine-metoclopramide inhibition of CB-154-induced prolactin suppression in rats: neurotransmitter-metabolite correlations.
    Lipham LB; Porter JK; Norred WP; Booth NH; Robbins JD
    Proc Soc Exp Biol Med; 1987 Mar; 184(3):250-5. PubMed ID: 2881309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of quipazine and D-fenfluramine, two serotonin-like drugs, on TSH secretion in basal and cold stimulated conditions in the rat.
    Di Renzo GF; Quattrone A; Schettini G; Preziosi P
    Life Sci; 1978 Jun; 22(21):1879-85. PubMed ID: 672433
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.